S Brillanti

Summary

Publications

  1. ncbi Triple antiviral therapy as a new option for patients with interferon nonresponsive chronic hepatitis C
    S Brillanti
    Department of Internal Medicine and Gastroenterology, Policlinico S Orsola Malpighi, University of Bologna, Italy
    Hepatology 32:630-4. 2000
  2. ncbi Slowly tapering off steroids protects the graft against hepatitis C recurrence after liver transplantation
    Stefano Brillanti
    Department of Internal Medicine and Gastroenterology, University of Bologna, Italy
    Liver Transpl 8:884-8. 2002
  3. ncbi Role of amantadine and other adjuvant therapies in the treatment of hepatitis C
    Stefano Brillanti
    University of Bologna, Bologna, Italy
    Semin Liver Dis 24:89-95. 2004
  4. ncbi Pilot study of triple antiviral therapy for chronic hepatitis C in interferon alpha non-responders
    S Brillanti
    Department of Internal Medicine and Gastroenterology, Policlinico S Orsola, University of Bologna, Italy
    Ital J Gastroenterol Hepatol 31:130-4. 1999
  5. ncbi Higher doses of peginterferon alpha-2b administered twice weekly improve sustained virological response in difficult-to-treat patients with chronic hepatitis C: results of a pilot randomized study
    F Lodato
    Department of Internal Medicine and Gastroenterology, University of Bologna, Bologna, Italy
    J Viral Hepat 12:536-42. 2005
  6. ncbi Peginterferon-based therapy for chronic hepatitis C virus infection in patients with normal alanine aminotransferase levels
    Stefano Brillanti
    Ann Intern Med 139:W83. 2003
  7. ncbi Low recurrence rate of hepatocellular carcinoma after liver transplantation: better patient selection or lower immunosuppression?
    Marco Vivarelli
    Department of Surgery and Transplantation, University of Bologna, Bologna, Italy
    Transplantation 74:1746-51. 2002

Detail Information

Publications7

  1. ncbi Triple antiviral therapy as a new option for patients with interferon nonresponsive chronic hepatitis C
    S Brillanti
    Department of Internal Medicine and Gastroenterology, Policlinico S Orsola Malpighi, University of Bologna, Italy
    Hepatology 32:630-4. 2000
    ..The safety profile was similar in the 2 groups. In conclusion, in patients with interferon-nonresponsive chronic hepatitis C, triple antiviral therapy for 1 year results in a high rate of sustained biochemical and virologic responses...
  2. ncbi Slowly tapering off steroids protects the graft against hepatitis C recurrence after liver transplantation
    Stefano Brillanti
    Department of Internal Medicine and Gastroenterology, University of Bologna, Italy
    Liver Transpl 8:884-8. 2002
    ..In conclusion, our results seem to indicate that in HCV-infected liver transplant recipients, a long-term treatment with corticosteroids, slowly tapered off over time, may prevent the more aggressive forms of recurrent liver disease...
  3. ncbi Role of amantadine and other adjuvant therapies in the treatment of hepatitis C
    Stefano Brillanti
    University of Bologna, Bologna, Italy
    Semin Liver Dis 24:89-95. 2004
    ..In this article, the author reviews the role of amantadine alone or as part of combination therapy regimens for chronic hepatitis C and briefly looks at the use of other agents as potential adjuvants...
  4. ncbi Pilot study of triple antiviral therapy for chronic hepatitis C in interferon alpha non-responders
    S Brillanti
    Department of Internal Medicine and Gastroenterology, Policlinico S Orsola, University of Bologna, Italy
    Ital J Gastroenterol Hepatol 31:130-4. 1999
    ..No effective therapy exists for interferon non-responding chronic hepatitis C patients...
  5. ncbi Higher doses of peginterferon alpha-2b administered twice weekly improve sustained virological response in difficult-to-treat patients with chronic hepatitis C: results of a pilot randomized study
    F Lodato
    Department of Internal Medicine and Gastroenterology, University of Bologna, Bologna, Italy
    J Viral Hepat 12:536-42. 2005
    ....
  6. ncbi Peginterferon-based therapy for chronic hepatitis C virus infection in patients with normal alanine aminotransferase levels
    Stefano Brillanti
    Ann Intern Med 139:W83. 2003
  7. ncbi Low recurrence rate of hepatocellular carcinoma after liver transplantation: better patient selection or lower immunosuppression?
    Marco Vivarelli
    Department of Surgery and Transplantation, University of Bologna, Bologna, Italy
    Transplantation 74:1746-51. 2002
    ..Immunosuppression represents a risk factor for tumor growth; the schedules of the immunosuppressant drugs have been modified through the years, aiming to reduce their dosage to the effective minimum...